Mazyar Shadman, M.D., M.P.H.

faculty member

Mazyar Shadman, M.D., M.P.H.

Assistant Member
Clinical Research Division, Fred Hutch

Fax: 206.667.1874
Mailstop: D5-390

Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.

Other Appointments & Affiliations

Attending Physician, Hematologic Malignancies
Seattle Cancer Care Alliance

Assistant Professor, Medical Oncology Division
University of Washington School of Medicine

Education

M.D., Tehran University of Medical Sciences, 2004

Internal Medicine Residency, Cleveland Clinic, 2008-2011

Hematology and Medical Oncology fellowship, University of Washington/Fred Hutchinson Cancer Research Center, 2011-2014

M.P.H., Cancer Epidemiology, University of Washington, 2008

Research Interests

Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)

Clinical outcome research in hematopoietic cell transplantation

Epidemiology of hematologic malignancies

Dr. Shadman in the News

Science without borders

Hutch News - October 16, 2017

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.